India’s biotechnology-led economy is experiencing significant momentum, with the country’s bioeconomy reaching a valuation of $195 billion in 2025, up from $166 billion in 2024.
According to the latest report published by the Biotechnology Industry Research Assistance Council (BIRAC), this growth highlights the increasing contribution of diverse biotechnology sectors and reflects India’s growing strength in the global innovation ecosystem.
The report highlights that India’s bioeconomy grew by $29.6 billion in 2025, achieving a strong 18% increase—the fastest pace recorded in recent years.
As stated in the report:
”These four emerging trends and new product areas, along with the other traditional biotechnology segments, have led to India’s BioEconomy adding $29.6 billion in 2025. This 18% growth is the highest witnessed in the last few years,”
The definition of the bioeconomy has evolved beyond traditional biopharma and industrial biotechnology. Today, it encompasses a wide array of sectors, including:
This diversification highlights how biotechnology is becoming deeply embedded across industries, making a substantial contribution to India’s overall economic output.
The report identifies four primary drivers behind this expansion:
The Biotechnology Industry Research Assistance Council has played a pivotal role in fostering innovation across a wide range of sectors, including:
Its support spans grants, equity investments, mentorship programmes, and strategic partnerships.
Rajesh S Gokhale, Secretary of the Department of Biotechnology, highlighted BIRAC’s contribution, stating:
”In just 14 years, BIRAC has helped transform Indian biotechnology from a small, fragmented sector into a vibrant innovation-driven ecosystem,”
He also pointed out that BIRAC has facilitated investments worth ₹7,000 crore, enabling:
Jitendra Kumar, Managing Director of BIRAC, outlined a bold vision for the sector, stating:
”Our ambition is bold: to grow India’s bioeconomy to $300 billion by 2030 and $1 trillion by 2047. With strong foundations in vaccines, biopharma, agribiotech, bioindustrial manufacturing, and clean energy, India is steadily emerging as a top global biotech innovation hub.”
With strong capabilities in vaccine manufacturing, pharmaceutical development, and agricultural biotechnology, India is gradually emerging as a key global centre for innovation in the biotechnology sector.
India’s bioeconomy touching $195 billion in 2025 underscores the country’s rapid shift toward a knowledge-based and innovation-driven economic model. This expansion is not limited to conventional biotechnology segments but is also being powered by emerging areas such as biofuels, digital biology, and sustainable industrial technologies. Government-led initiatives, including ethanol blending programmes and startup-focused support, have played a significant role in sustaining this growth momentum.
Simultaneously, rising global demand for biotech solutions, increased investments, and the steady expansion of Global Capability Centers have strengthened India’s position within the global value chain. The sector is also contributing meaningfully to employment generation and technological progress across industries.
Looking ahead, India’s targets of achieving a $300 billion bioeconomy by 2030 and $1 trillion by 2047 highlight a strong and forward-looking vision. With ongoing innovation, supportive policies, and deeper industry collaboration, the bioeconomy is expected to emerge as a key driver of India’s long-term sustainable economic and technological development.